A detailed kinetic study of Mox-1, a plasmid-encoded class C β-lactamase

FEMS Microbiology Letters

Volumn 225, Issue 2, 2003, Pages 183-188

  Alba, Jimena ^a,b   Bauvois, Cedric ^c   Ishii, Yoshikazu ^a   Galleni, Moreno ^c   Masuda, Katsuyoshi ^d   Ishiguro, Masaji ^d   Ito, Masahiko ^b   Frere, Jean Marie ^c   Yamaguchi, Keizo ^a  

^a TOHO UNIVERSITY   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d SUNTORY INSTITUTE FOR BIOORGANIC RESEARCH   (Japan)

Author keywords

Class C lactamase; Drug resistance; Kinetic Study; Mox 1

Indexed keywords

AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE MOX 1; CARBAPENEM DERIVATIVE; CEFALOTIN; CEFCAPENE; CEFDINIR; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTIZOXIME; CLAVULANIC ACID; CLOXACILLIN; ENZYME; IMIPENEM; LATAMOXEF; OXACILLIN; PENICILLIN G; PIPERACILLIN; S 4461; TAZOBACTAM; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CEPHAMYCIN DERIVATIVE; ENZYME INHIBITOR;

AMINO TERMINAL SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; CLONING VECTOR; CONTROLLED STUDY; ENZYME PURIFICATION; GENE; ION EXCHANGE CHROMATOGRAPHY; KINETICS; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; AMINO ACID SEQUENCE; CLASSIFICATION; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; ISOELECTRIC POINT; ISOLATION AND PURIFICATION; KLEBSIELLA PNEUMONIAE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BETA-LACTAMASES; CEPHAMYCINS; DRUG RESISTANCE, BACTERIAL; ENZYME INHIBITORS; ISOELECTRIC POINT; KINETICS; KLEBSIELLA PNEUMONIAE; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PLASMIDS; SUBSTRATE SPECIFICITY;

EID: 0642364321     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(03)00448-8     Document Type: Article

References (38)

1. Livermore D.M. Are all β-lactams created equal? Scand. J. Infect. Dis. 101:(Suppl.):1996;33-43.
2. Frere J.M. β-lactamases and bacterial resistance to antibiotics. Mol. Microbiol. 16:1995;385-395.
3. Frere J.M., Joris B., Granier B., Matagne A., Jacob F., Bourguignon-Bellefroid C. Diversity of the mechanisms of resistance to β-lactam antibiotics. Res. Microbiol. 142:1991;705-710.
4. Kotra L.P., Mobashery S. Mechanistic and clinical aspects of β-lactam antibiotics and β-lactamases. Arch. Immunol. Ther. Exp. 47:1999;211-216.
5. Matagne A., Dubus A., Galleni M., Frere J.M. The β-lactamase cycle: a tale of selective pressure and bacterial ingenuity. Nat. Prod. Rep. 16:1999;1-19.
6. Sandanayaka V.P., Prashad A.S. Resistance to β-lactam antibiotics: structure and mechanism based design of β-lactamase inhibitors. Curr. Med. Chem. 9:2002;1145-1165.
7. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science. 264:1994;375-382.
8. Bush K. New β-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin. Infect. Dis. 32:2001;1085-1089.
9. Ambler R.P. The structure of β-lactamases. Phil. Trans. R. Soc. Lond. B Biol. Sci. 289:1980;321-331.
10. Crichlow G.V., Nukaga M., Doppalapudi V.R., Buynak J.D., Knox J.R. Inhibition of class C β-lactamases: structure of a reaction intermediate with a cephem sulfone. Biochemistry. 40:2001;6233-6239.
11. Diaz N., Sordo T.L., Merz Jr K.M., Suarez D. Insights into the acylation mechanism of class A β-lactamases from molecular dynamics simulations of the TEM-1 enzyme complexed with benzylpenicillin. J. Am. Chem. Soc. 125:2003;672-684.
12. Bauernfeind A., Chong Y., Lee K. Plasmid-encoded AmpC β-lactamases: how far have we gone 10 years after the discovery? Yonsei Med. J. 39:1998;520-525.
13. Bradford P.A. What's new in β-lactamases? Curr. Infect. Dis. Rep. 3:2001;13-19.
14. Moland E.S., Black J.A., Ourada J., Reisbig M.D., Hanson N.D., Thomson K.S. Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 U.S. Hospitals. Antimicrob. Agents Chemother. 46:2002;3837-3842.
15. Vakulenko S.B., Golemi D., Geryk B., Suvorov M., Knox J.R., Mobashery S., Lerner S.A. Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 β-lactamase confers increased MIC of cefepime. Antimicrob. Agents Chemother. 46:2002 Jun;1966-1970.
16. Bauernfeind A., Stemplinger I., Jungwirth R., Giamarellou H. Characterization of the plasmidic β-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob. Agents Chemother. 40:1996;221-224.
17. Philippon A., Arlet G., Jacoby G.A. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46:2002;1-11.
18. Horii T., Arakawa Y., Ohta M., Ichiyama S., Wacharotayankun R., Kato N. Plasmid-mediated AmpC-type β-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum β-lactams, including moxalactam. Antimicrob. Agents Chemother. 37:1993;984-990.
19. Mercuri P.S., et al. Biochemical characterization of the FEZ-1 metallo-β-lactamase of Legionella gormanii ATCC 33297T produced in Escherichia coli. Antimicrob. Agents Chemother. 45:2001;1254-1262.
20. Segel, I.H. (1975) Rapid equilibrium partial and mixed-type inhibition. In: Enzyme Kinetics, Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, pp. 210-212. John Wiley and Sons, New York.
21. Afzal-Shah M., Villar H.E., Livermore D.M. Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina. J. Antimicrob. Chemother. 43:1999;127-131.
22. Giakkoupi P., Tzelepi E., Legakis N.J., Tzouvelekis L.S. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 β-lactamases. J. Antimicrob. Chemother. 43:1999;23-29.
23. Poirel L., Naas T., Le Thomas I., Karim A., Bingen E., Nordmann P. CTX-M-type extended-spectrum β-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob. Agents Chemother. 45:2001;3355-3361.
24. Jaurin B., Grundstrom T. ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of β-lactamases of the penicillinase type. Proc. Natl. Acad. Sci. USA. 78:1981;4897-4901.
25. Galleni M., Frere J.M. A survey of the kinetic parameters of class C β-lactamases. Penicillins. Biochem. J. 255:1988;119-122.
26. Papanicolaou G.A., Medeiros A.A., Jacoby G.A. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34:1990;2200-2209.
27. Horii T., Arakawa Y., Ohta M., Sugiyama T., Wacharotayankun R., Ito H., Kato N. Characterization of a plasmid-borne and constitutively expressed blaMOX-1 gene encoding AmpC-type β-lactamase. Gene. 139:1994;93-98.
28. Barlow M., Hall B.G. Origin and evolution of the AmpC β-lactamases of Citrobacter freundii. Antimicrob. Agents Chemother. 46:2002 May;1190-1198.
29. Bauernfeind A., Schneider I., Jungwirth R., Sahly H., Ullmann U. A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob. Agents Chemother. 43:1999;1924-1931.
30. Decre D., et al. Characterization of CMY-type β-lactamases in clinical strains of Proteus mirabilis and Klebsiella pneumoniae isolated in four hospitals in the Paris area. J. Antimicrob. Chemother. 50:2002;681-688.
31. Alba J., Ishii Y., Galleni M., Frere J.M., Ito M., Yamaguchi K. Cefcapene inactivates chromosome-encoded class C β-lactamases. J. Infect. Chemother. 8:2002;207-210.
32. Bret L., Chanal-Claris C., Sirot D., Chaibi E.B., Labia R., Sirot J. Chromosomally encoded ampC-type β-lactamase in a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 42:1998;1110-1114.
33. Livermore D.M. β-lactamase-mediated resistance and opportunities for its control. J. Antimicrob. Chemother. 41:1998;25-41.
34. Babini G.S., Danel F., Munro S.D., Micklesen P.A., Livermore D.M. Unusual tazobactam-sensitive AmpC β-lactamase from two Escherichia coli isolates. J. Antimicrob. Chemother. 41:1998;115-118.
35. Powers R.A., Morandi F., Shoichet B.K. Structure-based discovery of a novel, noncovalent inhibitor of AmpC β-lactamase. Structure. 10:2002;1013-1023.
36. Powers R.A., Shoichet B.K. Structure-based approach for binding site identification on AmpC β-lactamase. J. Med. Chem. 45:2002;3222-3234.
37. Trehan I., Beadle B.M., Shoichet B.K. Inhibition of AmpC β-lactamase through a destabilizing interaction in the active site. Biochemistry. 40:2001 Jul 10;7992-7999.
38. Kaur K., Lan M.J., Pratt R.F. Mechanism of inhibition of the class C β-lactamase of Enterobacter cloacae P99 by cyclic acyl phosph(on)ates: rescue by return. J. Am. Chem. Soc. 123:2001 Oct 31;10436-10443.